Good little article and a bit of publicity.
PPS is obviously disease modifying. Of that I have no doubt however what I'm looking forward to is finding out if it is DMOAD at our soon to be decided dose and regimen. Such a shame 008 was at a different dose than what we will most likely be using in the phase 3 trial
research reports and media, page-3956
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $87.44M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 25.0¢ | $4.436K | 17.69K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 26334 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 25596 | 4 |
View Market Depth
| Last trade - 11.40am 02/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |